首页 > 最新文献

Resuscitation plus最新文献

英文 中文
Innovative integration of wearable ECG monitoring vest and drone-delivered AED for high-rise for cardiac emergency rescue: a pilot study 可穿戴式心电监测背心与无人机交付高层心脏急救AED创新集成的试点研究
IF 2.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-01 DOI: 10.1016/j.resplu.2025.101206
Hong Jiang , Shouzheng Wang , Wenbin Ouyang , Mingbo Pan , Xiangbin Pan
{"title":"Innovative integration of wearable ECG monitoring vest and drone-delivered AED for high-rise for cardiac emergency rescue: a pilot study","authors":"Hong Jiang , Shouzheng Wang , Wenbin Ouyang , Mingbo Pan , Xiangbin Pan","doi":"10.1016/j.resplu.2025.101206","DOIUrl":"10.1016/j.resplu.2025.101206","url":null,"abstract":"","PeriodicalId":94192,"journal":{"name":"Resuscitation plus","volume":"27 ","pages":"Article 101206"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artesunate preserves post-resuscitation myocardial and neurologic function in a rat model of cardiac arrest and cardiopulmonary resuscitation 在心脏骤停和心肺复苏大鼠模型中,青蒿琥酯保留复苏后心肌和神经功能
IF 2.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-01 DOI: 10.1016/j.resplu.2025.101214
Hui Li , Cheng Cheng , Lian Liang , Tao Jin , Guozhen Zhang , Mary Ann Peberdy , Joseph P. Ornato , Wanchun Tang , Min Yang

Background

To investigate the effects of Artesunate (Art) on post-resuscitation myocardial and neurologic function, survival duration, and the underlying mechanisms in a rat model of cardiac arrest (CA) and cardiopulmonary resuscitation (CPR).

Methods

Thirty healthy male Sprague-Dawley rats were randomly allocated into three groups: Sham, Control(CA/CPR + vehicle),and ART(CA/CPR + Art). The latter two groups were further divided into survival and non-survival subgroups. CA were induced via 6-minute ventricular fibrillation, followed by 8 min of CPR. After the return of spontaneous circulation (ROSC), rats in the respective groups received either a vehicle or Art injection at random. Electrocardiogram (ECG) and arterial pressure were continuously monitored. In non-survival subgroups (euthanized 4 h post-ROSC), serum and tissue samples were analyzed for inflammatory cytokine concentrations, oxidative stress indices, myocardial injury markers, phosphorylated p38 (pp38), and echocardiography was performed. In survival subgroups, neurological deficit scores (NDS) were assessed at 24, 48, and 72 h post-ROSC, along with monitoring the duration of survival.

Results

Art reduced the severity of post-resuscitation myocardial dysfunction compared to control group. It attenuated interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and cardiac troponin I (cTnI) plasma levels 4 h after ROSC. In comparison with the control group, Art treatment led to a marked decrease in Thiobarbituric acid reactive species (TBARS) and 4-hydroxy-2-nonenal(4-HNE) expression, accompanied by upregulation of superoxide dismutases (SOD) activity in both heart and brain tissues. Art administration also downregulated the phosphorylation of p38. Post-resuscitation neurologic function and duration of survival were improved significantly in Art treated animals.

Conclusions

This study demonstrated that Art reduces the severity of post-resuscitation myocardial and neurologic dysfunction, improves survival duration in a rat model of CA. The underlying mechanism may be related to anti-inflammation, oxidative stress and may be associated with regulation of 4-HNE induced p38 Mitogen activated protein kinase (MAPK) pathway activation.
研究青蒿琥酯(Art)对心脏骤停(CA)和心肺复苏(CPR)大鼠复苏后心肌和神经功能、生存时间的影响及其潜在机制。方法健康雄性Sprague-Dawley大鼠30只,随机分为假手术组、对照组(CA/CPR +载药)和ART组(CA/CPR + ART)。后两组进一步分为生存亚组和非生存亚组。CA通过6分钟心室颤动诱发,随后进行8分钟心肺复苏术。自发循环恢复(ROSC)后,各组大鼠随机接受载体或Art注射。连续监测心电图(ECG)和动脉压。在非生存亚组(rosc后4小时安乐死)中,分析血清和组织样本的炎症细胞因子浓度、氧化应激指数、心肌损伤标志物、磷酸化p38 (pp38),并进行超声心动图检查。在生存亚组中,在rosc后24、48和72小时评估神经功能缺损评分(NDS),并监测生存时间。结果与对照组相比,art降低了复苏后心肌功能障碍的严重程度。它能降低ROSC后4小时血浆中白细胞介素-6 (IL-6)、肿瘤坏死因子-α (TNF-α)和心肌肌钙蛋白I (cTnI)水平。与对照组相比,Art治疗导致心脏和脑组织中硫代巴比妥酸活性物质(TBARS)和4-羟基-2-壬烯醛(4-HNE)表达显著降低,并伴有超氧化物歧化酶(SOD)活性上调。艺术管理也下调p38的磷酸化。Art治疗动物复苏后神经功能和生存时间明显改善。结论本研究表明,Art可减轻CA大鼠复苏后心肌和神经功能障碍的严重程度,延长存活时间,其潜在机制可能与抗炎症、氧化应激有关,并可能与4-HNE诱导的p38丝裂原活化蛋白激酶(MAPK)通路激活有关。
{"title":"Artesunate preserves post-resuscitation myocardial and neurologic function in a rat model of cardiac arrest and cardiopulmonary resuscitation","authors":"Hui Li ,&nbsp;Cheng Cheng ,&nbsp;Lian Liang ,&nbsp;Tao Jin ,&nbsp;Guozhen Zhang ,&nbsp;Mary Ann Peberdy ,&nbsp;Joseph P. Ornato ,&nbsp;Wanchun Tang ,&nbsp;Min Yang","doi":"10.1016/j.resplu.2025.101214","DOIUrl":"10.1016/j.resplu.2025.101214","url":null,"abstract":"<div><h3>Background</h3><div>To investigate the effects of Artesunate (Art) on post-resuscitation myocardial and neurologic function, survival duration, and the underlying mechanisms in a rat model of cardiac arrest (CA) and cardiopulmonary resuscitation (CPR).</div></div><div><h3>Methods</h3><div>Thirty healthy male Sprague-Dawley rats were randomly allocated into three groups: Sham, Control(CA/CPR + vehicle),and ART(CA/CPR + Art). The latter two groups were further divided into survival and non-survival subgroups. CA were induced via 6-minute ventricular fibrillation, followed by 8 min of CPR. After the return of spontaneous circulation (ROSC), rats in the respective groups received either a vehicle or Art injection at random. Electrocardiogram (ECG) and arterial pressure were continuously monitored. In non-survival subgroups (euthanized 4 h post-ROSC), serum and tissue samples were analyzed for inflammatory cytokine concentrations, oxidative stress indices, myocardial injury markers, phosphorylated p38 (pp38), and echocardiography was performed. In survival subgroups, neurological deficit scores (NDS) were assessed at 24, 48, and 72 h post-ROSC, along with monitoring the duration of survival.</div></div><div><h3>Results</h3><div>Art reduced the severity of post-resuscitation myocardial dysfunction compared to control group. It attenuated interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and cardiac troponin I (cTnI) plasma levels 4 h after ROSC. In comparison with the control group, Art treatment led to a marked decrease in Thiobarbituric acid reactive species (TBARS) and 4-hydroxy-2-nonenal(4-HNE) expression, accompanied by upregulation of superoxide dismutases (SOD) activity in both heart and brain tissues. Art administration also downregulated the phosphorylation of p38. Post-resuscitation neurologic function and duration of survival were improved significantly in Art treated animals.</div></div><div><h3>Conclusions</h3><div>This study demonstrated that Art reduces the severity of post-resuscitation myocardial and neurologic dysfunction, improves survival duration in a rat model of CA. The underlying mechanism may be related to anti-inflammation, oxidative stress and may be associated with regulation of 4-HNE induced p38 Mitogen activated protein kinase (MAPK) pathway activation.</div></div>","PeriodicalId":94192,"journal":{"name":"Resuscitation plus","volume":"27 ","pages":"Article 101214"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracorporeal cardiopulmonary resuscitation following cardiac surgery: a scoping review 心脏手术后体外心肺复苏:范围综述
IF 2.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-01 DOI: 10.1016/j.resplu.2025.101210
Sho Takemoto , Tomonari M. Shimoda , Yuta Inoue , Hirofumi Kanazawa , Amir Sanatkar , Asishana Osho , Ryan Ruiyang Ling , Kollengode Ramanathan , Akira Shiose , Yohei Okada

Background

In-hospital cardiac arrest after cardiac surgery demands specific approaches, such as rapid resternotomy, internal cardiac massage and sequential defibrillation. Extracorporeal cardiopulmonary resuscitation (ECPR) is a viable option; however, it is not standardized. This scoping review summarizes current evidence and identifies knowledge gaps regarding ECPR after cardiac surgery.

Methods

We searched PubMed, Web of Science, Cochrane Library, and Ichushi-Web (a Japanese medical database) from July 29, 2024 through March 20, 2025. Studies reporting outcomes in patients received ECPR after cardiac surgery were included, without restrictions on study design or language.

Results

Of 3963 unique articles, 49 studies were included. Among these, 3 adult and 17 pediatric studies reported ≥20 identifiable post–cardiac surgery ECPR cases (91 adult cases and 1464 pediatric cases). Across the included adult literature, only two ventricular assist device cases and no minimally invasive cardiac surgery cases were found. Adult post-cardiac surgery ECPR outcomes showed 33–35 % of overall survival and 23–29 % of survival with favorable neurological outcome. Pediatric outcomes were variable, with 10–70 % of overall survival and 10–40 % survival with favorable neurological outcome. Chest compression duration ranged from 31 to 36 min in adult post-cardiac surgery ECPR and from 27 to 60 min in pediatrics, where this metric was frequently available only from mixed surgical/non-surgical cohorts.

Conclusion

Both adult and pediatric groups demonstrated variable but relatively high overall survival and survival with favorable neurological outcome following ECPR. Pediatric studies highlighted prolonged chest compressions. Further research is needed to explore the role of ECPR following minimally invasive and ventricular assist device surgery.
背景:医院内心脏手术后心脏骤停需要特殊的治疗方法,如快速胸腔切开术、心脏内部按摩和序贯除颤。体外心肺复苏(ECPR)是一个可行的选择;然而,它并不是标准化的。本综述总结了目前的证据,并确定了关于心脏手术后ECPR的知识差距。方法我们从2024年7月29日至2025年3月20日检索PubMed、Web of Science、Cochrane Library和Ichushi-Web(日本医学数据库)。研究报告了心脏手术后接受ECPR的患者的结果,没有研究设计或语言的限制。结果在3963篇独立文献中,纳入49篇研究。其中,3项成人研究和17项儿科研究报告了≥20例可识别的心脏手术后ECPR病例(成人91例,儿科1464例)。在纳入的成人文献中,仅发现2例心室辅助装置病例,未发现微创心脏手术病例。成人心脏手术后ECPR结果显示,33 - 35%的总生存率和23 - 29%的生存率具有良好的神经预后。儿童预后是可变的,10 - 70%的总生存率和10 - 40%的生存率具有良好的神经预后。在成人心脏术后ECPR中,胸按压时间为31 - 36分钟,在儿科中为27 - 60分钟,这一指标通常只能从手术/非手术混合队列中获得。结论成人组和儿童组均表现出不同但相对较高的总生存率和生存率,ECPR术后神经预后良好。儿科研究强调长时间胸外按压。微创和心室辅助装置手术后ECPR的作用有待进一步研究。
{"title":"Extracorporeal cardiopulmonary resuscitation following cardiac surgery: a scoping review","authors":"Sho Takemoto ,&nbsp;Tomonari M. Shimoda ,&nbsp;Yuta Inoue ,&nbsp;Hirofumi Kanazawa ,&nbsp;Amir Sanatkar ,&nbsp;Asishana Osho ,&nbsp;Ryan Ruiyang Ling ,&nbsp;Kollengode Ramanathan ,&nbsp;Akira Shiose ,&nbsp;Yohei Okada","doi":"10.1016/j.resplu.2025.101210","DOIUrl":"10.1016/j.resplu.2025.101210","url":null,"abstract":"<div><h3>Background</h3><div>In-hospital cardiac arrest after cardiac surgery demands specific approaches, such as rapid resternotomy, internal cardiac massage and sequential defibrillation. Extracorporeal cardiopulmonary resuscitation (ECPR) is a viable option; however, it is not standardized. This scoping review summarizes current evidence and identifies knowledge gaps regarding ECPR after cardiac surgery.</div></div><div><h3>Methods</h3><div>We searched PubMed, Web of Science, Cochrane Library, and Ichushi-Web (a Japanese medical database) from July 29, 2024 through March 20, 2025. Studies reporting outcomes in patients received ECPR after cardiac surgery were included, without restrictions on study design or language.</div></div><div><h3>Results</h3><div>Of 3963 unique articles, 49 studies were included. Among these, 3 adult and 17 pediatric studies reported ≥20 identifiable post–cardiac surgery ECPR cases (91 adult cases and 1464 pediatric cases). Across the included adult literature, only two ventricular assist device cases and no minimally invasive cardiac surgery cases were found. Adult post-cardiac surgery ECPR outcomes showed 33–35 % of overall survival and 23–29 % of survival with favorable neurological outcome. Pediatric outcomes were variable, with 10–70 % of overall survival and 10–40 % survival with favorable neurological outcome. Chest compression duration ranged from 31 to 36 min in adult post-cardiac surgery ECPR and from 27 to 60 min in pediatrics, where this metric was frequently available only from mixed surgical/non-surgical cohorts.</div></div><div><h3>Conclusion</h3><div>Both adult and pediatric groups demonstrated variable but relatively high overall survival and survival with favorable neurological outcome following ECPR. Pediatric studies highlighted prolonged chest compressions. Further research is needed to explore the role of ECPR following minimally invasive and ventricular assist device surgery.</div></div>","PeriodicalId":94192,"journal":{"name":"Resuscitation plus","volume":"27 ","pages":"Article 101210"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of return of spontaneous circulation during cardiopulmonary resuscitation using continuous carotid artery Doppler blood flow monitored by AI in an animal model 人工智能监测动物颈动脉连续多普勒血流检测心肺复苏过程中自发循环的恢复
IF 2.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-01 DOI: 10.1016/j.resplu.2025.101207
Raghava Vinaykanth Mushunuri , Bjorn Ove Faldaas , Frank Lindseth , Charlotte Bjork Ingul , Gabriel Kiss

Background

Manual pulse checks during cardiopulmonary resuscitation (CPR) to confirm return of spontaneous circulation (ROSC) are often unreliable and time- consuming. To address this, a novel RescueDoppler device has been developed, consisting of a small ultrasound probe that attaches to the neck and continuously monitors potential blood flow in the carotid artery.

Aim

To provide automatic real-time feedback on ROSC using RescueDoppler carotid blood flow during cardiac arrest by employing advanced deep-learning techniques.

Method

We conducted two experiments using carotid blood flow velocity recordings from 9 pigs, with ventricular fibrillation induced via an implantable defibrillator. Experiment 1 included 2610 annotated heart cycles and used a simple classifier to distinguish compression (only manual) from ROSC signals. Experiment 2 involved 5140 cycles and employed a two- stage classifier: the first stage replicated Experiment 1, while the second further separated compression-only from compression with intrinsic cardiac activity. Two- second spectral signals were extracted, normalized, and artificial neural networks are trained for classifying the signals by using State-of-the-art deep learning models as feature extractors. Grad-CAM, an explainable AI (XAI) method, highlighted key regions which contributed most to the model’s predictions.

Results

Our model achieved mean sensitivity of 98 %, specificity of 97 %, positive predictive value of 97 %, and negative predictive value of 100 %. XAI heatmaps highlighted features important for the model’s predictions.

Conclusion

In a porcine model of cardiac arrest, we demonstrated that deep learning techniques can harness the potential of AI to identify the compressions with intrinsic cardiac activity and ROSC during CPR, achieving highly accurate results.
背景:在心肺复苏(CPR)过程中,通过人工脉搏检查来确认自动循环(ROSC)的恢复通常是不可靠且耗时的。为了解决这个问题,一种新型的RescueDoppler设备被开发出来,它由一个附着在脖子上的小超声探头组成,可以持续监测颈动脉的潜在血流量。通过采用先进的深度学习技术,利用RescueDoppler提供心脏骤停期间颈动脉血流的ROSC自动实时反馈。方法对9头经植入式除颤器诱发心室颤动的猪进行颈动脉血流速度记录实验。实验1包括2610个注释的心脏周期,并使用简单的分类器从ROSC信号中区分压缩(仅手动)。实验2涉及5140个循环,采用了两阶段分类器:第一阶段重复实验1,而第二阶段进一步分离了仅压缩和具有内在心脏活动的压缩。对两秒光谱信号进行提取、归一化,并使用最先进的深度学习模型作为特征提取器训练人工神经网络对信号进行分类。Grad-CAM是一种可解释的人工智能(XAI)方法,它突出了对模型预测贡献最大的关键区域。结果该模型的平均敏感性为98%,特异性为97%,阳性预测值为97%,阴性预测值为100%。XAI热图突出了模型预测的重要特征。在猪心脏骤停模型中,我们证明了深度学习技术可以利用人工智能的潜力来识别心肺复苏过程中具有内在心脏活动和ROSC的压迫,并获得了高度准确的结果。
{"title":"Detection of return of spontaneous circulation during cardiopulmonary resuscitation using continuous carotid artery Doppler blood flow monitored by AI in an animal model","authors":"Raghava Vinaykanth Mushunuri ,&nbsp;Bjorn Ove Faldaas ,&nbsp;Frank Lindseth ,&nbsp;Charlotte Bjork Ingul ,&nbsp;Gabriel Kiss","doi":"10.1016/j.resplu.2025.101207","DOIUrl":"10.1016/j.resplu.2025.101207","url":null,"abstract":"<div><h3>Background</h3><div>Manual pulse checks during cardiopulmonary resuscitation (CPR) to confirm return of spontaneous circulation (ROSC) are often unreliable and time- consuming. To address this, a novel RescueDoppler device has been developed, consisting of a small ultrasound probe that attaches to the neck and continuously monitors potential blood flow in the carotid artery.</div></div><div><h3>Aim</h3><div>To provide automatic real-time feedback on ROSC using RescueDoppler carotid blood flow during cardiac arrest by employing advanced deep-learning techniques.</div></div><div><h3>Method</h3><div>We conducted two experiments using carotid blood flow velocity recordings from 9 pigs, with ventricular fibrillation induced via an implantable defibrillator. Experiment 1 included 2610 annotated heart cycles and used a simple classifier to distinguish compression (only manual) from ROSC signals. Experiment 2 involved 5140 cycles and employed a two- stage classifier: the first stage replicated Experiment 1, while the second further separated compression-only from compression with intrinsic cardiac activity. Two- second spectral signals were extracted, normalized, and artificial neural networks are trained for classifying the signals by using State-of-the-art deep learning models as feature extractors. Grad-CAM, an explainable AI (XAI) method, highlighted key regions which contributed most to the model’s predictions.</div></div><div><h3>Results</h3><div>Our model achieved mean sensitivity of 98 %, specificity of 97 %, positive predictive value of 97 %, and negative predictive value of 100 %. XAI heatmaps highlighted features important for the model’s predictions.</div></div><div><h3>Conclusion</h3><div>In a porcine model of cardiac arrest, we demonstrated that deep learning techniques can harness the potential of AI to identify the compressions with intrinsic cardiac activity and ROSC during CPR, achieving highly accurate results.</div></div>","PeriodicalId":94192,"journal":{"name":"Resuscitation plus","volume":"27 ","pages":"Article 101207"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intubation during in-hospital cardiac arrest: an instrumental variable analysis 院内心脏骤停期间插管:工具变量分析
IF 2.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-01 DOI: 10.1016/j.resplu.2025.101202
Mathias J. Holmberg , Asger Granfeldt , Lars W. Andersen

Introduction

Tracheal intubation is commonly performed during in-hospital cardiac arrest, but the evidence for a survival benefit remains uncertain.

Methods

This was an observational study using data from the Get With The Guidelines registry. Adult patients with an in-hospital cardiac arrest between January 2013 and December 2021 were included. Instrumental variable analyses were conducted using two-stage least squares regression in an attempt to account for unmeasured confounding. Two instrumental variables were predefined as (1) tracheal intubation during the previous cardiac arrest and (2) the proportion of intubated cardiac arrest patients within the past year at a given hospital. The primary outcome was survival to hospital discharge. Secondary outcomes included return of spontaneous circulation and favorable neurological status.

Results

A total of 210,115 cardiac arrests were included. The median age was 67 years, 59 % of patients were male, and 85 % of patients had an initial non-shockable rhythm. Intubation was performed in 85 % of patients. For the first and second instrumental variables, tracheal intubation was associated with absolute risk differences in survival of −11 % (95 % CI, −16 % to −5.6 %) and −12 % (95 % CI, −16 % to −8.2 %), respectively. Similar results were observed for the secondary outcomes.

Conclusions

Tracheal intubation during in-hospital cardiac arrest was associated with reduced survival, although point estimates were implausibly large, and the results should be interpreted cautiously. Preference-based instrumental variables may not adequately address confounding in this setting. Randomized clinical trials are needed to inform advanced airway management during in-hospital cardiac arrest.
气管插管通常在院内心脏骤停期间进行,但对生存益处的证据仍不确定。方法:这是一项观察性研究,使用来自指南注册的数据。纳入了2013年1月至2021年12月期间发生院内心脏骤停的成年患者。使用两阶段最小二乘回归进行工具变量分析,试图解释未测量的混杂。两个工具变量被预先定义为(1)先前心脏骤停期间的气管插管和(2)过去一年内在给定医院插管的心脏骤停患者的比例。主要终点是存活至出院。次要结果包括自然循环的恢复和良好的神经系统状态。结果共纳入心脏骤停210,115例。中位年龄为67岁,59%的患者为男性,85%的患者有初始非休克性心律。85%的患者进行了插管。对于第一和第二个工具变量,气管插管与生存的绝对风险差异相关,分别为- 11% (95% CI, - 16%至- 5.6%)和- 12% (95% CI, - 16%至- 8.2%)。在次要结果中也观察到类似的结果。结论院内心脏骤停期间气管插管与生存率降低相关,尽管点估值大得令人难以置信,结果应谨慎解释。在这种情况下,基于偏好的工具变量可能无法充分解决混淆问题。需要随机临床试验来告知院内心脏骤停期间的高级气道管理。
{"title":"Intubation during in-hospital cardiac arrest: an instrumental variable analysis","authors":"Mathias J. Holmberg ,&nbsp;Asger Granfeldt ,&nbsp;Lars W. Andersen","doi":"10.1016/j.resplu.2025.101202","DOIUrl":"10.1016/j.resplu.2025.101202","url":null,"abstract":"<div><h3>Introduction</h3><div>Tracheal intubation is commonly performed during in-hospital cardiac arrest, but the evidence for a survival benefit remains uncertain.</div></div><div><h3>Methods</h3><div>This was an observational study using data from the Get With The Guidelines registry. Adult patients with an in-hospital cardiac arrest between January 2013 and December 2021 were included. Instrumental variable analyses were conducted using two-stage least squares regression in an attempt to account for unmeasured confounding. Two instrumental variables were predefined as (1) tracheal intubation during the previous cardiac arrest and (2) the proportion of intubated cardiac arrest patients within the past year at a given hospital. The primary outcome was survival to hospital discharge. Secondary outcomes included return of spontaneous circulation and favorable neurological status.</div></div><div><h3>Results</h3><div>A total of 210,115 cardiac arrests were included. The median age was 67 years, 59 % of patients were male, and 85 % of patients had an initial non-shockable rhythm. Intubation was performed in 85 % of patients. For the first and second instrumental variables, tracheal intubation was associated with absolute risk differences in survival of −11 % (95 % CI, −16 % to −5.6 %) and −12 % (95 % CI, −16 % to −8.2 %), respectively. Similar results were observed for the secondary outcomes.</div></div><div><h3>Conclusions</h3><div>Tracheal intubation during in-hospital cardiac arrest was associated with reduced survival, although point estimates were implausibly large, and the results should be interpreted cautiously. Preference-based instrumental variables may not adequately address confounding in this setting. Randomized clinical trials are needed to inform advanced airway management during in-hospital cardiac arrest.</div></div>","PeriodicalId":94192,"journal":{"name":"Resuscitation plus","volume":"27 ","pages":"Article 101202"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence and prognostic impact of delirium after cardiac arrest: a systematic review and meta-analysis 心脏骤停后谵妄的发生率和预后影响:一项系统回顾和荟萃分析
IF 2.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-01 DOI: 10.1016/j.resplu.2025.101195
Saeed Khayat Kakhki , Majid Daneshfar , Mehrdad Yousefnezhad , Alireza NamaeiQasemnia

Background

Delirium is common after ROSC, yet reported incidence varies widely across studies that differ in instruments, assessment windows, and post-arrest care. We aimed to quantify the incidence of delirium among adult post-ROSC ICU survivors and evaluate its association with short-term mortality.

Methods

The review was reported according to PRISMA guidelines and registered on PROSPERO (CRD420251160097). PubMed, Embase, Scopus, and Web of Science were searched from 2000 to 30 Sep 2025 without language restrictions. Eligible studies enrolled adults (≥18 years) with ROSC admitted to ICU and reported ICU-period delirium using validated tools (CAM-ICU, ICDSC, DSM-based diagnosis) or structured screening scales. Proportions were pooled on the logit scale using random-effects models with Hartung–Knapp adjustment. Prespecified sensitivity analyses included validated tools only, exclusion of non-validated instruments, and binomial–normal GLMM.

Results

Eleven studies (n = 1799) met inclusion criteria. The pooled ICU-period incidence of delirium was 0.43 (95 % CI 0.16–0.75) with a wide prediction interval (≈0.01–0.98), reflecting substantial heterogeneity largely driven by assessment instrument and ICU ascertainment window rather than patient factors. Findings were robust in binomial–normal GLMM analyses and in influence/sensitivity analyses. Delirium was consistently associated with greater resource use (longer ICU and hospital length of stay) and, in the two post-ROSC cohorts reporting adjusted models, signaled higher short-term mortality; larger CICU/AMI cohorts provided concordant mortality signals.

Conclusions

Delirium affects roughly two in five ICU survivors after ROSC and its measured incidence depends strongly on how and when it is assessed. Standardizing to validated tools and a common ICU window could narrow heterogeneity and improve comparability. These results support routine delirium screening and prevention as core elements of post-arrest care.
背景:ROSC术后谵妄很常见,但不同研究报告的发病率差异很大,研究工具、评估窗口和骤停后护理不同。我们的目的是量化rosc后ICU成人幸存者谵妄的发生率,并评估其与短期死亡率的关系。方法根据PRISMA指南报道,在PROSPERO注册(CRD420251160097)。检索自2000年至2025年9月30日的PubMed、Embase、Scopus和Web of Science,无语言限制。符合条件的研究纳入了入住ICU并报告ICU期间谵妄的ROSC成人(≥18岁),使用经过验证的工具(CAM-ICU, ICDSC,基于dsm的诊断)或结构化筛查量表。采用Hartung-Knapp调整的随机效应模型在logit标度上汇总比例。预先指定的敏感性分析只包括经过验证的工具,排除未经验证的工具和二项正态GLMM。结果17项研究(n = 1799)符合纳入标准。合并ICU期间谵妄发生率为0.43 (95% CI 0.16-0.75),预测区间较宽(≈0.01-0.98),反映了主要由评估工具和ICU确定窗口而非患者因素驱动的实质性异质性。在二项正态GLMM分析和影响/敏感性分析中,结果是稳健的。谵妄始终与更多的资源使用(更长的ICU和住院时间)相关,并且在两个rosc后报告调整模型的队列中,预示着更高的短期死亡率;较大的CICU/AMI队列提供了一致的死亡率信号。结论:ROSC后谵妄影响约五分之二的ICU幸存者,其测量的发生率在很大程度上取决于评估的方式和时间。标准化有效的工具和共同的ICU窗口可以缩小异质性并提高可比性。这些结果支持常规谵妄筛查和预防作为骤停后护理的核心要素。
{"title":"Incidence and prognostic impact of delirium after cardiac arrest: a systematic review and meta-analysis","authors":"Saeed Khayat Kakhki ,&nbsp;Majid Daneshfar ,&nbsp;Mehrdad Yousefnezhad ,&nbsp;Alireza NamaeiQasemnia","doi":"10.1016/j.resplu.2025.101195","DOIUrl":"10.1016/j.resplu.2025.101195","url":null,"abstract":"<div><h3>Background</h3><div>Delirium is common after ROSC, yet reported incidence varies widely across studies that differ in instruments, assessment windows, and post-arrest care. We aimed to quantify the incidence of delirium among adult post-ROSC ICU survivors and evaluate its association with short-term mortality.</div></div><div><h3>Methods</h3><div>The review was reported according to PRISMA guidelines and registered on PROSPERO (CRD420251160097). PubMed, Embase, Scopus, and Web of Science were searched from 2000 to 30 Sep 2025 without language restrictions. Eligible studies enrolled adults (≥18 years) with ROSC admitted to ICU and reported ICU-period delirium using validated tools (CAM-ICU, ICDSC, DSM-based diagnosis) or structured screening scales. Proportions were pooled on the logit scale using random-effects models with Hartung–Knapp adjustment. Prespecified sensitivity analyses included validated tools only, exclusion of non-validated instruments, and binomial–normal GLMM.</div></div><div><h3>Results</h3><div>Eleven studies (<em>n</em> = 1799) met inclusion criteria. The pooled ICU-period incidence of delirium was 0.43 (95 % CI 0.16–0.75) with a wide prediction interval (≈0.01–0.98), reflecting substantial heterogeneity largely driven by assessment instrument and ICU ascertainment window rather than patient factors. Findings were robust in binomial–normal GLMM analyses and in influence/sensitivity analyses. Delirium was consistently associated with greater resource use (longer ICU and hospital length of stay) and, in the two post-ROSC cohorts reporting adjusted models, signaled higher short-term mortality; larger CICU/AMI cohorts provided concordant mortality signals.</div></div><div><h3>Conclusions</h3><div>Delirium affects roughly two in five ICU survivors after ROSC and its measured incidence depends strongly on how and when it is assessed. Standardizing to validated tools and a common ICU window could narrow heterogeneity and improve comparability. These results support routine delirium screening and prevention as core elements of post-arrest care.</div></div>","PeriodicalId":94192,"journal":{"name":"Resuscitation plus","volume":"27 ","pages":"Article 101195"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wolf Creek XVIII Part 2: optimizing time intervals in cardiac arrest care Wolf Creek XVIII第2部分:优化心脏骤停护理的时间间隔
IF 2.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2026-01-01 DOI: 10.1016/j.resplu.2025.101197
Theresa M. Olasveengen , Haruka Takahashi , Rudolph W. Koster , Gavin D. Perkins , Robert W. Neumar
Optimizing time intervals in cardiac arrest care was a featured topic at the 50th Anniversary Wolf Creek Conference (Wolf Creek XVIII) hosted by the Max Harry Weil Institute for Critical Care Research and Innovation in Ann Arbor, Michigan, USA on June 19–21, 2025. This narrative review summarizes the presentations and discussion of the topic by invited panelist and conference participants made up of international academic and industry scientists as well as thought leaders in the field of cardiac arrest resuscitation. The proceedings highlighted the limitations of binary proportion-based resuscitation metrics (e.g. “bystander CPR—yes/no”) in driving improvements in cardiac arrest outcomes and called for a paradigm shift—placing time intervals to key cardiac arrest interventions and responses to therapy at the center of benchmarking quality improvement and research. In addition to an overview of the current state and vision for the future state, we detail knowledge gaps and barriers to translation, and propose research priorities that include standardizing interval measurement, harmonizing reporting, and validating interval metrics for system performance and proximal outcomes. Making treatment and response intervals core metrics for systems-of-care, registries, and clinical trials could shift the field’s focus toward the goal of faster restoration of perfusion resulting in improved survival and better neurologic recovery.
2025年6月19日至21日,美国密歇根州安娜堡市,由马克斯·哈里·威尔重症监护研究与创新研究所主办的Wolf Creek 50周年会议(Wolf Creek XVIII)上,优化心脏骤停护理的时间间隔是一个特色主题。这篇叙述性综述总结了由国际学术和行业科学家以及心脏骤停复苏领域的思想领袖组成的特邀小组成员和会议参与者对该主题的演讲和讨论。会议记录强调了基于二元比例的复苏指标(例如“旁观者cpr是/否”)在推动心脏骤停结果改善方面的局限性,并呼吁范式转换——将关键心脏骤停干预和治疗反应的时间间隔置于基准质量改进和研究的中心。除了概述当前状态和对未来状态的展望之外,我们还详细介绍了知识差距和翻译障碍,并提出了研究重点,包括标准化间隔测量、协调报告和验证系统性能和最近结果的间隔度量。将治疗和反应间隔作为护理系统、注册和临床试验的核心指标,可以将该领域的重点转向更快地恢复灌注,从而提高生存率和更好的神经系统恢复。
{"title":"Wolf Creek XVIII Part 2: optimizing time intervals in cardiac arrest care","authors":"Theresa M. Olasveengen ,&nbsp;Haruka Takahashi ,&nbsp;Rudolph W. Koster ,&nbsp;Gavin D. Perkins ,&nbsp;Robert W. Neumar","doi":"10.1016/j.resplu.2025.101197","DOIUrl":"10.1016/j.resplu.2025.101197","url":null,"abstract":"<div><div>Optimizing time intervals in cardiac arrest care was a featured topic at the 50th Anniversary Wolf Creek Conference (Wolf Creek XVIII) hosted by the Max Harry Weil Institute for Critical Care Research and Innovation in Ann Arbor, Michigan, USA on June 19–21, 2025. This narrative review summarizes the presentations and discussion of the topic by invited panelist and conference participants made up of international academic and industry scientists as well as thought leaders in the field of cardiac arrest resuscitation. The proceedings highlighted the limitations of binary proportion-based resuscitation metrics (e.g. “bystander CPR—yes/no”) in driving improvements in cardiac arrest outcomes and called for a paradigm shift—placing time intervals to key cardiac arrest interventions and responses to therapy at the center of benchmarking quality improvement and research. In addition to an overview of the current state and vision for the future state, we detail knowledge gaps and barriers to translation, and propose research priorities that include standardizing interval measurement, harmonizing reporting, and validating interval metrics for system performance and proximal outcomes. Making treatment and response intervals core metrics for systems-of-care, registries, and clinical trials could shift the field’s focus toward the goal of faster restoration of perfusion resulting in improved survival and better neurologic recovery.</div></div>","PeriodicalId":94192,"journal":{"name":"Resuscitation plus","volume":"27 ","pages":"Article 101197"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemolysis correction factor in the reporting of serum neuron-specific enolase – Clinical utility in neuroprognostication after cardiac arrest 血清神经元特异性烯醇化酶报告中的溶血校正因子——心脏骤停后神经预后的临床应用
IF 2.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-24 DOI: 10.1016/j.resplu.2025.101208
Christina Jungar , Erik Alinder , Charlotte Becker , Marion Moseby-Knappe , Anna Lybeck

Background

Neuron-specific enolase (NSE) from 48 h after cardiac arrest is the only biomarker of brain injury with recommended cut-offs for use in neuroprognostication. Hemolysis elevates levels of NSE and may result in false outcome predictions.

Methods

A correction-factor for hemolysis in reporting of levels of NSE was established and evaluated in (1) incoming routine samples and (2) biobank samples from 48 h after cardiac arrest from the SweCrit biobank. Comparisons were made with three methods for handling hemolysis: Hemolysis Index (HI) 30 mg/dL or HI 50 mg/dL as the highest acceptable level of hemolysis, or a graded approach.

Results

Five-hundred and fifty-six routine samples and 263 biobank samples were analyzed. A correction factor of 0.33 µg/L per HI significantly increased the number of reported routine samples, when compared to the three other methods for handling hemolysis (HI 30 mg/dL or HI 50 mg/dL as the highest acceptable level of hemolysis, or a graded approach). Use of the correction factor did not affect the number of reported biobank samples. The prognostic accuracy of NSE was unaffected by use of the correction factor compared to the other tested methods for handling hemolysis: area under the curve (AUC) 0.88 (95 % Cl 0.84–0.92) vs 0.87 (95 % Cl 0.83–0.92) at HI ≤ 30 mg/dL, 0.87 (95 % Cl 0.83–0.92) at HI ≤ 50 mg/dL and 0.87 (95 % CI 0.83–0.92) with the graded approach. Levels of hemolysis were low in the biobank samples.

Conclusion

Due to the low levels of hemolysis in the biobank samples, the effects of a correction factor on neuroprognostication after cardiac arrest in routine samples remains uncertain. Clinical use of a correction factor may lead to more reported samples but risks over-correction.
背景:心脏骤停后48小时的神经元特异性烯醇化酶(NSE)是脑损伤的唯一生物标志物,被推荐用于神经预后。溶血可提高NSE水平,并可能导致错误的预后预测。方法建立溶血报告NSE水平的校正因子,并对(1)输入的常规样本和(2)SweCrit生物库中心脏骤停后48 h的生物库样本进行评估。比较了三种处理溶血的方法:溶血指数(HI) 30 mg/dL或HI 50 mg/dL作为溶血的最高可接受水平,或分级方法。结果共检测常规标本556份,生物库标本263份。与其他三种处理溶血的方法(30mg /dL或50mg /dL作为溶血的最高可接受水平,或分级方法)相比,每个HI的校正因子0.33 μ g/L显著增加了报告的常规样品数量。校正因子的使用不影响报告的生物样本数量。与处理溶血的其他测试方法相比,NSE的预后准确性不受使用校正因子的影响:曲线下面积(AUC)为0.88 (95% Cl 0.84-0.92), HI≤30 mg/dL时为0.87 (95% Cl 0.83-0.92), HI≤50 mg/dL时为0.87 (95% Cl 0.83-0.92),分级方法为0.87 (95% CI 0.83-0.92)。生物样本的溶血水平较低。结论由于生物样本中溶血水平较低,校正因子对常规样本心脏骤停后神经预后的影响尚不确定。临床使用校正因子可能导致更多的报告样本,但存在过度校正的风险。
{"title":"Hemolysis correction factor in the reporting of serum neuron-specific enolase – Clinical utility in neuroprognostication after cardiac arrest","authors":"Christina Jungar ,&nbsp;Erik Alinder ,&nbsp;Charlotte Becker ,&nbsp;Marion Moseby-Knappe ,&nbsp;Anna Lybeck","doi":"10.1016/j.resplu.2025.101208","DOIUrl":"10.1016/j.resplu.2025.101208","url":null,"abstract":"<div><h3>Background</h3><div>Neuron-specific enolase (NSE) from 48 h after cardiac arrest is the only biomarker of brain injury with recommended cut-offs for use in neuroprognostication. Hemolysis elevates levels of NSE and may result in false outcome predictions.</div></div><div><h3>Methods</h3><div>A correction-factor for hemolysis in reporting of levels of NSE was established and evaluated in (1) incoming routine samples and (2) biobank samples from 48 h after cardiac arrest from the SweCrit biobank. Comparisons were made with three methods for handling hemolysis: Hemolysis Index (HI) 30 mg/dL or HI 50 mg/dL as the highest acceptable level of hemolysis, or a graded approach.</div></div><div><h3>Results</h3><div>Five-hundred and fifty-six routine samples and 263 biobank samples were analyzed. A correction factor of 0.33 µg/L per HI significantly increased the number of reported routine samples, when compared to the three other methods for handling hemolysis (HI 30 mg/dL or HI 50 mg/dL as the highest acceptable level of hemolysis, or a graded approach). Use of the correction factor did not affect the number of reported biobank samples. The prognostic accuracy of NSE was unaffected by use of the correction factor compared to the other tested methods for handling hemolysis: area under the curve (AUC) 0.88 (95 % Cl 0.84–0.92) vs 0.87 (95 % Cl 0.83–0.92) at HI ≤ 30 mg/dL, 0.87 (95 % Cl 0.83–0.92) at HI ≤ 50 mg/dL and 0.87 (95 % CI 0.83–0.92) with the graded approach. Levels of hemolysis were low in the biobank samples.</div></div><div><h3>Conclusion</h3><div>Due to the low levels of hemolysis in the biobank samples, the effects of a correction factor on neuroprognostication after cardiac arrest in routine samples remains uncertain. Clinical use of a correction factor may lead to more reported samples but risks over-correction.</div></div>","PeriodicalId":94192,"journal":{"name":"Resuscitation plus","volume":"28 ","pages":"Article 101208"},"PeriodicalIF":2.4,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145969131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Negative Pressure Performance Between Certified and Counterfeit Suction-based Devices 认证和假冒吸式设备负压性能的比较
IF 2.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-22 DOI: 10.1016/j.resplu.2025.101203
Nino Fijačko , Špela Metličar , Inja Dokl , Aleš Fajmut
{"title":"Comparison of Negative Pressure Performance Between Certified and Counterfeit Suction-based Devices","authors":"Nino Fijačko ,&nbsp;Špela Metličar ,&nbsp;Inja Dokl ,&nbsp;Aleš Fajmut","doi":"10.1016/j.resplu.2025.101203","DOIUrl":"10.1016/j.resplu.2025.101203","url":null,"abstract":"","PeriodicalId":94192,"journal":{"name":"Resuscitation plus","volume":"27 ","pages":"Article 101203"},"PeriodicalIF":2.4,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Terminology Matters: Distinguishing Bystanders from First Responders in Resuscitation Science 术语问题:在复苏科学中区分旁观者和急救人员
IF 2.4 Q3 CRITICAL CARE MEDICINE Pub Date : 2025-12-20 DOI: 10.1016/j.resplu.2025.101201
Sergio Cazorla-Calderón , Nino Fijačko , Robert Greif
{"title":"Terminology Matters: Distinguishing Bystanders from First Responders in Resuscitation Science","authors":"Sergio Cazorla-Calderón ,&nbsp;Nino Fijačko ,&nbsp;Robert Greif","doi":"10.1016/j.resplu.2025.101201","DOIUrl":"10.1016/j.resplu.2025.101201","url":null,"abstract":"","PeriodicalId":94192,"journal":{"name":"Resuscitation plus","volume":"27 ","pages":"Article 101201"},"PeriodicalIF":2.4,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Resuscitation plus
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1